SEC Comment Letter for PAVmed Inc. (PAVM) (CIK 0001624326) (PAVM) — Oct 3, 2017
PAVmed Inc. (PAVM) (CIK 0001624326)
Date: Oct. 3, 2017 · CIK: 0001624326 · Accession: 0000000000-17-035099
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-220549
Letter
Mail Stop 3030 October 3, 2017 Via E -mail Lishan Aklog, M.D. Chief Executive Officer PAVmed Inc. One Grand Central Place, Suite 4600 New York, New York 10165
Re: PAVmed Inc. Registration Statement on Form S-3 Filed September 21, 2017 File No. 333-220549
Dear Dr. Aklog :
This is to advise you that we have not reviewed and will not review your registration statement .
Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Please contact Heather Percival at (202) 551 -3498 with any questions.
Sincerely,
/s/ Heather Percival for
Show Raw Text
Mail Stop 3030 October 3, 2017 Via E -mail Lishan Aklog, M.D. Chief Executive Officer PAVmed Inc. One Grand Central Place, Suite 4600 New York, New York 10165 Re: PAVmed Inc. Registration Statement on Form S-3 Filed September 21, 2017 File No. 333-220549 Dear Dr. Aklog : This is to advise you that we have not reviewed and will not review your registration statement . Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Heather Percival at (202) 551 -3498 with any questions. Sincerely, /s/ Heather Percival for Amanda Ravitz Assistant Director Office of Electronics and Machinery cc: David Alan Miller, Esq. Graubard Miller